Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?
J Psychopharmacol April 22, 2021 Robin Carhart-Harris, Anne C Wagner, Manish Agrawal et al. 54 citations
Favourable regulatory assessments, liberal policy changes, new research centres and substantial commercial investment signal that psychedelic therapy is making a major comeback. Positive findings from modern trials are catalysing developments, but it is questionable whether current confirmatory trials are sufficient for advancing our understanding of safety and best practice. Here we suggest...